Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Biotech
Therapeutics
Drug discovery
Oncology
Biotechnology
About
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada